Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Probenecid Inhibits Respiratory Syncytial Virus (RSV) Replication
Jackelyn Murray, Harrison C. Bergeron, Les Jones, et al.
Viruses (2022) Vol. 14, Iss. 5, pp. 912-912
Open Access | Times Cited: 16

Showing 16 citing articles:

Anti-G protein antibodies targeting the RSV G protein CX3C chemokine region improve the interferon response
Harrison C. Bergeron, Lawrence M. Kauvar, Ralph A. Tripp
Therapeutic Advances in Infectious Disease (2023) Vol. 10
Open Access | Times Cited: 13
Probenecid Inhibits Influenza A(H5N1) and A(H7N9) Viruses In Vitro and in Mice
Jackelyn Murray, David E. Martin, Sarah Hosking, et al.
Viruses (2024) Vol. 16, Iss. 1, pp. 152-152
Open Access | Times Cited: 5
Respiratory Syncytial Virus Infection: Treatments and Clinical Management
Shiza Malik, Tahir Ahmad, Khalid Muhammad, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 491-491
Open Access | Times Cited: 12
Layer-by-Layer Microparticle Vaccines Containing a S177Q Point Mutation in the Central Conserved Domain of the RSV G Protein Improves Immunogenicity
Harrison C. Bergeron, Jackelyn Murray, Maria G. Juarez, et al.
Viral Immunology (2025)
Closed Access
Comparative study of the effects of baicalin and probenecid on microRNA expression profiles in porcine aortic vascular endothelial cells infected by Glaesserella parasuis
Ling Guo, Yaqiong Yang, Linrong Yang, et al.
BMC Veterinary Research (2025) Vol. 21, Iss. 1
Open Access
Probenecid Inhibits Human Metapneumovirus (HMPV) Replication In Vitro and in BALB/c Mice
Harrison C. Bergeron, Jackelyn Crabtree, Tamás Nagy, et al.
Viruses (2024) Vol. 16, Iss. 7, pp. 1087-1087
Open Access | Times Cited: 3
Linking chemicals, genes and morphological perturbations to diseases
Natacha Cerisier, Bryan Dafniet, Anne Badel, et al.
Toxicology and Applied Pharmacology (2023) Vol. 461, pp. 116407-116407
Open Access | Times Cited: 8
Screening Drugs for Broad-Spectrum, Host-Directed Antiviral Activity: Lessons from the Development of Probenecid for COVID-19
Ralph A. Tripp, David E. Martin
Viruses (2023) Vol. 15, Iss. 11, pp. 2254-2254
Open Access | Times Cited: 8
Antiviral Activity of Probenecid and Oseltamivir on Influenza Virus Replication
Jackelyn Murray, David E. Martin, Fred D. Sancilio, et al.
Viruses (2023) Vol. 15, Iss. 12, pp. 2366-2366
Open Access | Times Cited: 7
N-Acetyl-L-Cysteine Protects Airway Epithelial Cells during Respiratory Syncytial Virus Infection against Mucin Synthesis, Oxidative Stress, and Inflammatory Response and Inhibits HSPA6 Expression
Lei Chi, Yuxia Shan, Zhenze Cui
Analytical Cellular Pathology (2022) Vol. 2022, pp. 1-9
Open Access | Times Cited: 12
Immunogenicity and protective efficacy of an RSV G S177Q central conserved domain nanoparticle vaccine
Harrison C. Bergeron, Jackelyn Murray, Maria G. Juarez, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Microparticle RSV Vaccines Presenting the G Protein CX3C Chemokine Motif in the Context of TLR Signaling Induce Protective Th1 Immune Responses and Prevent Pulmonary Eosinophilia Post-Challenge
Thomas Powell, Alice K. Jacobs, Jie Tang, et al.
Vaccines (2022) Vol. 10, Iss. 12, pp. 2078-2078
Open Access | Times Cited: 8
Immune Prophylaxis Targeting the Respiratory Syncytial Virus (RSV) G Protein
Harrison C. Bergeron, Jackelyn Murray, Aakash Arora, et al.
Viruses (2023) Vol. 15, Iss. 5, pp. 1067-1067
Open Access | Times Cited: 3
Reclassification of respiratory syncytial virus genotypes in India
Sai Suresh Bandla, Rushil Bhatt, Santhosha Devadiga
VirusDisease (2022) Vol. 34, Iss. 1, pp. 1-14
Closed Access | Times Cited: 2
The continuing need for therapeutic agents for respiratory syncytial virus infection
Norbert J. Roberts
Antiviral chemistry & chemotherapy (2023) Vol. 31
Open Access
Two synthetic steroid analogs reduce human respiratory syncytial virus replication and the immune response to infection both in vitro and in vivo
Carlos Alberto Bueno, Franco Maximiliano Salinas, Lourdes Vázquez, et al.
Heliyon (2023) Vol. 9, Iss. 10, pp. e20148-e20148
Open Access
Page 1

Scroll to top